Human signal transducer and activator of transcription 3 (STAT3) is one of many genes containing a tandem splicing site. Alternative donor splice sites 3 nucleotides apart result in either the inclusion (S) or exclusion (ΔS) of a single residue, Serine-701. Further downstream, splicing at a pair of alternative acceptor splice sites result in transcripts encoding either the 55 terminal residues of the transactivation domain (α) or a truncated transactivation domain with 7 unique residues (β). As outlined in this manuscript, measuring the proportions of STAT3's four spliced transcripts (Sα, Sβ, ΔSα and ΔSβ) was possible using absolute qPCR (quantitative polymerase chain reaction). The protocol therefore distinguishes and measures highly similar splice variants. Absolute qPCR makes use of calibrator plasmids and thus specificity of detection is not compromised for the sake of efficiency. The protocol necessitates primer validation and optimization of cycling parameters. A combination of absolute qPCR and efficiency-dependent relative qPCR of total STAT3 transcripts allowed a description of the fluctuations of STAT3 splice variants' levels in eosinophils treated with cytokines. The protocol also provided evidence of a co-splicing interdependence between the two STAT3 splicing events. The strategy based on a combination of the two qPCR techniques should be readily adaptable to investigation of cosplicing at other tandem splicing sites.
Introduction
Short-range (tandem) alternative splicing, where alternate acceptor or donor sites are in close proximity to one another, is common in mammals 1 , invertebrates 2 and plants 3 . It is estimated that 20% of mammalian genes contain alternative splice sites 2-12 nucleotides apart 4 . Many of these sites are 3 nucleotides apart and result in inclusion or exclusion of a single codon. There is debate about the nature of splicing regulation at these sites 5, 6 with some arguing that the splicing motif differences are so subtle that selection is stochastic 7 , while others infer regulation based on tissue specificity 8 .
Tandem splice site selection has been analyzed semi-quantitatively using modified capillary electrophoresis 7 , and high-resolution gel electrophoresis 8 . RNA-Seq (RNA sequencing) reads can be used to quantify the splicing ratios at each splice site. In this way, RNA-Seq data has provided insight into the regulation of tandem splice sites 9 . It has also enabled prediction of expected splice variant ratios based on nucleotide motif 10 . Most of the emphasis on splicing that includes or excludes a single codon has been on the more commonly occurring tandem acceptor splice sites, known as NAGNAGs (where N = any nucleotide).
Tandem donor alternative splice sites including or excluding a single codon (GYNGYN recognition motif, where Y = pyrimidine) are less common than tandem acceptors. Signal transducer and activator of transcription 3 (STAT3) is a key gene undergoing tandem donor alternative splicing 1, 11 . The tandem donor splice sites join exons 21 and 22 and result in the inclusion or exclusion of the codon for Serine-701 (S or ΔS respectively) 1, 11 . Downstream alternative acceptor sites (40 nucleotides apart from each other) joining exons 22 and 23a/b result in the inclusion of either the 55 terminal residues of the transactivation domain (α) or a truncated transactivation domain with 7 unique C-terminal residues (β) 11 . Therefore, four splice variants are possible.
STAT3 protein is a transcription factor and major signal integrator in numerous cell types 12 and when mutated its constitutive activation contributes to several cancer phenotypes (reviewed in reference 13 ). Job's Syndrome, an immunodeficiency disorder characterized by high levels of IgE, is also caused by mutations in STAT3 (reviewed in reference 14 ). Distinct roles for STAT3 α and β splice variant proteins have been previously described 15 . Initially, STAT3 β was thought to act in a dominant-negative manner 16 , antagonizing STAT3 α's transcriptional activity, but subsequent work suggested it has independent target genes 17 . Despite the subtlety of tandem splicing, there is reason to believe the absence or presence of Serine-701 (Ser701) influences function. Not only is Ser701 in close proximity to Tyrosine-705 (the residue phosphorylated in STAT3 activation . The biological relevance remains to be explored. Given that splice variant composition could influence function, we endeavored to discover whether the ratio was perturbed by cytokine stimulation in eosinophils.
We initially attempted to explore the linkage between the two splicing events by using PCR specific for STAT3 α and β splice variants, followed by cleavage of products with a restriction enzyme specific for the S splice variants, AfeI. Densitometry of products indicated inclusion of Ser701 was roughly ten times more common than its omission (ΔS) in both STAT3 α and β (data not shown). However, this semi-quantitative approach was not sufficiently reproducible, and could not be used effectively to measure all four splice variants simultaneously. To analyze proportions of each of the four splice variants, it was necessary to establish a quantitative PCR (qPCR) protocol that yielded tight technical (several assays of a given sample) replicates.
Relative qPCR relies on comparison of a gene of interest to a standard or housekeeping gene known to be expressed at a particular level 20 and is appropriate when the gene of interest and housekeeping gene are amplified with similar efficiency. A double stranded (ds) DNAbinding fluorescent (cyanine) dye binds to PCR amplicons 21 , and after a certain number of cycles, sufficient amplification has occurred for fluorescence to be detectable. The higher the initial level of the transcript, the lower the threshold cycle (Ct) value. Since the concentration of cDNA preparations differs, one needs to compare the transcript's concentration with the concentration of a transcript known to be expressed at a consistent level in all samples, like glucuronidase-β (GUSB) in eosinophils 22 .
Relative qPCR is not feasible for highly similar sequences, as seen in splice variants resulting from tandem splicing. The stringent conditions required to specifically amplify the splice variants result in decreased efficiency. Instead, absolute quantification must be used 23 . This entails preparing a standard curve with known concentrations of the spliced transcript of interest, and ensuring PCR conditions optimize specificity 24 . As described, absolute and relative qPCR data for a particular gene can be merged to inform understanding of the gene's expression in a particular cell type, in this case STAT3 in variously stimulated eosinophils 25 .
Herein, STAT3 splice variant quantification is described with the expectation that the method can be adapted to targeted studies of other tandem splicing events. Optimization was a lengthy process, where several primer pairs at various concentrations and numerous iterations of cycling parameters were tested over the course of a few months. The key features of the protocol are primer specificity validation and quantification based on standard curves with known concentrations of the splice variants. Relative qPCR in conjunction proved helpful for our application but is not necessary.
Creating Plasmids as Template Standards
1. Create primers for an amplicon spanning both STAT3 splice sites, with 5'-KpnI and NheI restriction sites (and 5'-extensions) as per Table 1a .
NOTE: KpnI and NheI sites were chosen to enable inserts to be ligated into a modified pET-28a vector with kanamycin resistance 25, 26 . KpnI site had been added into the multiple cloning site. 2 . Excise bands from the gel and purify according to gel excision kit instructions. 5. Cut amplicons and plasmid with appropriate restriction enzymes (overview of restriction in reference 27 ), using volumes, incubation times and temperatures recommended by enzyme provider; and purify as in step 1.4. Ligate restricted amplicons into plasmid under providerrecommended conditions. 6. Prepare a negative control (restricted plasmid DNA without insert but with ligase) and a positive control (unrestricted plasmid with kanamycin resistance). Perform standard plasmid transformations of competent E. coli DH5α 28 using ligation mixtures 27 . 7. Incubate transformed E. coli in 1 ml Luria-Broth (LB) medium (prepared as instructed 27 ) shaking for 1 hr at 37 °C. Spread transformants on LB plates containing 50 µg/ml kanamycin and incubate at 37 °C overnight. 8. Pick several colonies from the STAT3 α and STAT3 β plates using sterile toothpicks 27 . Transfer each to 2 ml LB. Grow cultures overnight at 37 °C in a shaking incubator. 2. Use diluted plasmids to prepare four "non-target" mixes (i.e., STAT3ΔSβ negative control containing equal concentrations of STAT3 Sα, ΔSα, Sβ but no ΔSβ) at 10 6 copies per µl each. Prepare a "target" mix with equal concentrations of all four templates each at 10 6 copies per µl.
3. Prepare primer pair solutions for each splice variant (see Table 1b and Figure 1 ) by making ~60 µl of primers each at a 7 µM concentration (final concentration in sample will be 560 nM). 4. Dilute DNA polymerase/dsDNA-binding dye mix 7:5 with pure H 2 O. 5. Set up Assay 1 in a 96-well PCR plate as shown in template ( Table 3 ).
1. Add 21 µl diluted DNA polymerase/dsDNA-binding dye mix, then 2 µl of primer mix and 2 µl of template (as per Where y is Ct, m is the gradient, x is log(copy number) and b is the intercept value. NOTE: The R 2 value of the linear regression will be ≥0.95 for good data.
Assessing Absolute qPCR Assay Specificity and Repeatability
3. Calculate amplification efficiency using standard curve and the equation:
NOTE: Aim for efficiency ≥75%. 4. Calculate specificity from qPCR assay 1 using Too's formula:
Where ΔCt Too = Ct target -Ct non-target , describing the difference in threshold cycle number for specific and non-specific amplification NOTE: Specificity should exceed four orders of magnitude (i.e., specificity factor ≥4). 1. If specificity is poor, optimize by lowering primer concentration. Set up assays (as described in steps 2.5-2.7) with final primer concentrations ranging from 100 nM to 500 nM.
Performing Relative qPCR Assays
1. Treat Cells with Cytokines to Promote Transcription. 1. For freshly donated eosinophils, prepare duplicate samples of 2.5 x 10 6 cells/ml in cell culture medium (RPMI 1640 medium) and treat with 50 ng/ml interleukin-3 (IL3) and/or 50 ng/ml tumor necrosis factor α (TNFα) for periods of 3, 6, 9 and 20 hr at 37 °C under 5% CO 2 and 10% humidity.
and cDNA synthesis kits. 3. Prepare serial dilutions of two sample cDNA aliquots (control or resting samples), with a dilution range from "1" to "1 in 1024" dilution.
1. For the 1 in 4 dilution, pipette 1 µl cDNA and 3 µl ultrapure water. 2. For the 1 in 16 dilution, pipette 1 µl of the 1 in 4 dilution and 3 µl ultrapure water, etc.
4. Set up PCR in 96-well plate with 25 µl reactions as described steps 2.3-2.5 but with several primer concentrations for pan-STAT3 and GUSB (see template in Table 4 ). 5. Add "new detector" for GUSB and follow steps 2.6-2.7, using the cycling parameters described in Table 2c . 6. Generate standard curves (see steps 3.2 and 3.3) to determine which primer concentrations result in 95-100% amplification efficiency. 7. Set up plate with prepared cDNA samples (from Step 4.2) and optimized primer concentrations (see Table 2c for cycling parameters, reagents and 12. Calculate fold-increase for each sample:
13. Reproducibility 1. Calculate the coefficient of variation (CV) of copy number for pan-STAT3 and GUSB.
Where N = number of samples, = sample's calculated copy number and = sample mean. Check that CV of each sample (multiple assays) is ≤10%. = 11 times more concentrated. Perform a 1:1 dilution with ultrapure water within the same range without diluting more than necessary). NOTE: Vastly different starting concentrations will bias the linear regression analysis (step 4.12).
Analyzing Absolute qPCR Data for Unknown Samples
2. Set up absolute qPCR assay of samples. Prepare assay 2a template plate for Sα and Sβ as per Table 6 ; and prepare assay 2b for ΔSα and ΔSβ as per Table 7 . Carry out assays as described in steps 2.6-2.7.3 (and Table 2b ). Repeat assays at least once. 3. Check data quality and export as described in steps 2.7.4-2.7.5. 4. Set up absolute qPCR 96 well plate with 25 µl reactions using pan-STAT3 primers (primers in Table 1c , template in Table 8 ) at 400 µM and a mix of all four plasmids or a single plasmid at listed total concentrations. NOTE: Efficiency does not matter for absolute qPCR, but optimizing efficiency of these primers is important for relative qPCR (Step 4). 5. Seal qPCR plate with adhesive cover and centrifuge for 5 min at 1,200 x g at 12 °C. 6. Set up "new detector" for pan-STAT3 as in steps 2.7.1-2.7.3. 7. Set up cycling for pan-STAT3 as per Table 2c (same conditions as relative qPCR). Ensure that fluorescence reading (to determine Ct) occurs during the 72 °C step of each cycle. Repeat assay at least once to ensure reproducibility. 8. Check data quality and export (see steps 2.7.4-2.7.5).
1. If amplification plots are not exponential (see Figure 2) , dilute sample cDNA (1:10) and repeat assay as described (step 5.7).
9. Using the equation of the standard curve (see 3.2, Figure 3 ) and the Ct values of samples, calculate the copy number of each splice variant and of pan-STAT3 in each sample.
10. Plot log (absolute qPCR copy number values obtained for pan-STAT3) vs log (cumulative absolute qPCR copy number values for STAT3 splice variants). NOTE: Ideal linear regression and slope values would both be ~1. 11. Calculate repeatability (Step 3.1) and reproducibility (Step 4.13).
Merging Absolute and Relative qPCR Data Representative Results
Good quality qPCR data will generate a sigmoidal amplification plot (Figure 2a) , signifying exponential increase in transcripts over the course of cycling. The presence of too much template can result in a high fluorescence background, meaning an inappropriate baseline is established in the first few cycles. If the data do not provide an exponential curve (Figure 2b) , further optimization is necessary (outlined in steps 3.1 and 3.4). For further information about troubleshooting qPCR results, refer to reference 32 . The standard curves generated for the template calibrator plasmids will indicate the efficiency of amplification (curve for STAT3 Sα shown in Figure 3) . Efficiencies between 83 and 95% were observed under the conditions described. The equation for specificity (Step 3.4) assumes equal efficiency, which is unlikely 25 , so the specificity is likely to be greater than specificity factor suggests.
In order to evaluate the congruency of STAT3 levels, the absolute values of each of the four splice variants were measured as well as the level of total STAT3, the latter using primers amplifying a region common to all four splice variants (Figure 4) . Ideally the linear regression (indication of correlation) and slope (ratio of pan-STAT3 to summed splice variants) should both be close to 1.
The absolute qPCR data are presented as pie charts to show the proportions of the four splice variants over time post-stimulation with cytokines (Figure 5a) . Resting eosinophils (0 hr) had the smallest proportion of STAT3 Sα, although this variant was always the most abundant. Multiplying the fraction of STAT3 β splice variants (Sβ+ΔSβ) by the fraction of STAT3 ΔS splice variants (ΔSα+ΔSβ) consistently gave a value lower than the experimentally-recorded value for ΔSβ. If the splicing events were independent, one would expect that multiplying fraction of ΔS variants by the fraction of β variants would give a value that agrees with the experimentally-determined value. Higher levels of ΔSβ than expected from independent splicing events suggests a co-splicing bias exists.
Merging absolute and relative qPCR data demonstrated that levels of all STAT3 splice variants increased post-stimulation with cytokines IL3 and TNFα, with levels peaking 6 hr post-stimulation (Figure 5b-e) . For three of the four splice variants, transcript levels were roughly 3 times higher in IL3+TNFα treated eosinophils (6 hr) compared to eosinophils in media at the same time point. STAT3 Sα levels were 3.5 times higher in IL3+TNFα treated eosinophils compared to eosinophils in media at this time point. The greatest uncertainty (largest standard error of measurement) was seen in ΔSβ (Figure 5e) , which comprises the smallest fraction of total STAT3 in all samples. This was not surprising, as lower levels are associated with higher Ct values. Requiring more cycles to reach the threshold cycle will compound uncertainty due to cycle-tocycle variation in efficiency of amplification. Table 3 : Template for absolute qPCR plasmid calibration assay. This assay is necessary to assess reproducibility and efficiency, as well as generating standard curves from which to interpolate data. The "non-target" mixes will give an estimate of specificity. Optimization may be necessary to achieve consistency. Please click here to view a larger version of this table. Table 4 : Template for relative qPCR (pan-STAT3 and housekeeping gene GUSB) calibration assay. Unlike absolute qPCR, the point of this assay is to determine conditions at which amplification efficiency is ~100%. Please click here to view a larger version of this table. 
Discussion
We developed this protocol in order to assess the levels and proportions of STAT3 splice variant transcripts in eosinophils and lymphoma cells and learn whether cytokine stimulation affected the levels and proportions. STAT3 is of particular interest because of its pleiotropic and uncertain functionality, with conflicting reports on whether it acts as an oncoprotein or tumor suppressor in cancer (reviewed in reference 33 ). Differences in STAT3 α and β splice variant function had been characterized previously 34, 35 , and our protocol facilitated a knock-down/re-expression analysis that suggests a need for an optimal ratio of S and ΔS transcripts 19 .
Accurate quantification of distinct splice variants will facilitate further investigations of relating heterogeneous STAT3 function to splice variant composition. The protocol integrates absolute and relative qPCR data, combining the ability of absolute qPCR to calculate splice variant proportions, and relative qPCR to measure changes in overall STAT3 expression. This approach allows one to distinguish subtle differences in sequence and simultaneously measure splicing ratios at two alternative splice sites more than 50 nucleotides apart. Determining the ratios of the splicing events individually would not have yielded the remarkable finding that a co-splicing bias existed such that ΔSβ levels are higher than anticipated if uses of the two sites are randomly spliced 25 .
Critically, absolute qPCR with the use of plasmid calibration curves enables quantification (at sub-optimal efficiency) of splice variations that result in highly similar sequences. We anticipate a novel subtle splicing qPCR assay should take roughly two months to optimize. Key steps in assay development are the creation of STAT3 plasmids used in generating standard curves for absolute qPCR; experimentally determining optimal primer sequences and cycling parameters to ensure specificity and reproducibility; and the integration of relative qPCR data derived from quantifying pan-STAT3 expression relative to GAPDH expression. The correlation of copy number quantified by pan-STAT3 versus cumulative quantification (Sα+ΔSα+Sβ+ΔSβ) shows that the protocol produces reliable results.
A caveat of the technique is the extensive validation process. It is necessary to assess intra-assay variability (repeatability), interassay variability (reproducibility) and specificity. The protocol outlines ways to get numeric outputs for these parameters. We deemed efficiency ≥75%, specificity factor ≥4, coefficient of variation (reproducibility) ≤10% and Ct standard deviation (repeatability) ≤0.2 as suitable thresholds 30 . Mutations or deletions in the STAT3 sequence amino acids 1-690 will not be discovered by this protocol, although they may influence splicing ratios. Transcript proportions might not be proportional to proteoform proportions 36 .
Since samples have differing starting amounts of total cDNA, absolute qPCR is suitable for comparing copy numbers of splice variants within a sample but not for inter-sample comparison unless coupled with relative qPCR using an established housekeeping gene. The method described conforms to MIQE qPCR guidelines for reproducibility 30 . PCR cycling parameters and primer concentrations may need to be modified to obtain reproducible data if other equipment is used. Perfect specificity is not possible without drastically compromising efficiency, but the target was amplified more efficiently by greater than four of orders of magnitude.
Linear DNA is more easily amplified than circular. If an alternate plasmid does not provide satisfactory standard curves (R 2 < 0.95), consider linearizing the plasmid by single site restriction prior to quantification. Optimizing qPCR is crucial for obtaining good quality data (Figure 1) . Most qPCR protocols rely on two-step cycling, and machines are optimized accordingly. Non-uniform heating of the heating block may be exacerbated in three-step cycling, contributing to poor repeatability. Assays must be set up under sterile conditions with filter pipette tips and ultrapure water, ideally in a dedicated laminar flow hood. Because contaminants can lead to inconsistent results, assays should be set up under sterile conditions with filter pipette tips and ultrapure water, ideally in a dedicated laminar flow hood. For more information about qPCR optimization, refer to Bustin et al. 32 Quantifying STAT3 may lead to greater insight in a number of contexts. STAT3 auto-regulates its own expression 37 , and the protocol described above may help to elucidate whether ratios of STAT3 splice variants contribute to regulating this positive feedback loop. The protocol could be used to study shifts in splice variant ratios as observed in cells at differing densities 38 or over the course of development: it is known that the STAT3 α/β ratio changes at the protein level during hematopoiesis 16 . Sundin et al. found that an intronic single nucleotide polymorphism biased splicing of exon 12 in STAT3 of a patient with Job's syndrome 39 . It is conceivable that one of the many SNPs present in the introns between exon 21 and 22, or exon 22 and 23 may contribute to splicing ratios of ΔS/S and α/β respectively. The assay could be used to quantify STAT3 transcripts in cancerous cells, where mutations or changes in splicing regulation may introduce bias to the splicing process 40 . Mutations in splicing factors (like SF3B1), as observed in myelodysplastic syndromes 41 may also lead to changes that can be measured by this protocol.
More broadly, this approach specifically detects co-association in splicing, which is not feasible with conventional RNA-Seq, nor standard qPCR. While the phenomenon of mutually exclusive exon splicing demonstrates coordination of splicing decisions, the co-association of other splicing events has not been well-researched. A recently described alternative method, in which RNA-Seq was modified so as to interrogate full-length cDNA, suggests distant splicing events are more co-dependent than previously thought
